Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

June 29, 2018July 3, 2018

Pulmonary Fibrosis Foundation Launches Help Line for Oxygen Equipment

News

The Pulmonary Fibrosis Foundation (PFF) has launched its Oxygen Information Line to provide information and resources to help people using supplemental oxygen and their caregivers. Using the line, people can ... Read more

April 30, 2018April 30, 2018

Researchers Discover Natural Mechanism That Resolves Lung Fibrosis in Mice

News

Scientists found that a special kind of white blood cell could potentially be stimulated to migrate to the lungs of idiopathic pulmonary fibrosis (IPF) patients and help repair fibrosis ... Read more

April 25, 2018April 26, 2018

Genentech’s Esbriet More Effective in Patients with Rapidly Progressing IPF, Study Finds

News

The rate of decline in lung function in patients with idiopathic pulmonary fibrosis (IPF) before they are treated with Genentech‘s Esbriet (pirfenidone) influences the effects of the medication, researchers have ... Read more

April 2, 2018April 2, 2018

Ofev Preserves Pulmonary Function of IPF Patients Awaiting a Lung Transplant, Study Finds

News

Boehringer Ingelheim‘s Ofev (nintedanib) preserved the lung function of nine idiopathic pulmonary fibrosis patients waiting for a lung transplant, a study reported. The research, “Safety of nintedanib before lung ... Read more

March 26, 2018March 26, 2018

Lung Transplant Can Benefit Those with PF-Linked Hermansky-Pudlak Syndrome, Study Reports

News

A lung transplant can benefit those whose pulmonary fibrosis (PF) stems from Hermansky-Pudlak syndrome (HPS), a study indicate. The study, “Clinical management and outcomes of patients with Hermansky-Pudlak syndrome ... Read more

February 22, 2018February 22, 2018

PMD Healthcare Creating Pulmonary Fibrosis Patient Advisory Board

News

PMD Healthcare is creating advisory boards composed of pulmonary fibrosis and cystic fibrosis patients and caregivers. The company, whose services include remote monitoring of patients’ health conditions, is in the midst ... Read more

January 19, 2018January 19, 2018

Pulmonary Fibrosis Foundation to Expand Its US Care Center Network

News

The Pulmonary Fibrosis Foundation plans to expand its U.S. Care Center Network from the existing 45 facilities, which provide diagnosis and treatment. The network started with nine sites when it ... Read more

December 22, 2017December 22, 2017

FDA Grants Orphan Drug Status to Prometic’s Pulmonary Fibrosis Therapy Ryplazim

News

The U.S. Food and Drug Administration has granted orphan drug status to Prometic Life Sciences’ Ryplazim (plasminogen) as a treatment for idiopathic pulmonary fibrosis. Fewer than 200,000 Americans have ... Read more

November 9, 2017November 9, 2017

ATS Foundation and Boehringer Ingelheim Establish Fellowship for Pulmonary Fibrosis Research

News

The American Thoracic Society and Boehringer Ingelheim have established a two-year, $100,000 fellowship for idiopathic pulmonary fibrosis research. Pulmonary fibrosis is a group of lung diseases characterized by cough, shortness of ... Read more

September 11, 2017September 11, 2017

Boehringer Ingelheim and Inventiva Extend Their IPF Therapy Development Partnership

News

Boehringer Ingelheim has extended its collaboration with Inventiva on developing treatments for tissue-scarring conditions such as idiopathic pulmonary fibrosis, or IPF. The company exercised an option to continue the partnership, which began ... Read more

Pin It on Pinterest